Nisa Investment Advisors’s scPharmaceuticals SCPH Stock Holding History

Nisa Investment Advisors’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-295	Closed	-$1.67K	–	3067
2025 Q3	$1.67K	Hold	295	–	–	﹤0.01%	2655
2025 Q2	$1.12K	Buy	295 +202	+217%	+$627	﹤0.01%	2714
2025 Q1	$245	Sell	93 -38	-29%	-$124	﹤0.01%	2902
2024 Q4	$464	Sell	131 -17	-11%	-$65	﹤0.01%	2841
2024 Q3	$675	Buy	148 +4	+3%	+$19	﹤0.01%	2665
2024 Q2	$626	Buy	+144	New	+$633	﹤0.01%	2638

Nisa Investment Advisors's SCPH Position: Q4 2025 in Review

Nisa Investment Advisors sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 295 shares — an estimated $1.67K sold.

Nisa Investment Advisors first reported a position in SCPH in Q2 2024 and held it in 6 quarters. The position peaked at $1.67K in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Nisa Investment Advisors reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Nisa Investment Advisors sold 295 scPharmaceuticals shares in Q4 2025, an estimated $1.67K.
Nisa Investment Advisors first reported a position in scPharmaceuticals in Q2 2024 and held it in 6 quarters.
Nisa Investment Advisors's scPharmaceuticals position peaked at $1.67K in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Nisa Investment Advisors's 13F filing for Q4 2025, filed 15 Jan 2026.